Conclusion
VT ablation in patients with CKD results in increased incidence of adverse clinical events such as greater in-hospital mortality and acute kidney injury, in addition to increased length of stay and higher hospital charges. CKD IV and III had higher hospital mortality and 30-day readmission rate, respectively compared with other CKD stages. Understanding risk of VT ablation in patients with different stages of CKD will inform discussions of risks and benefits of of patients with CKD being considered for catheter ablation of VT.